First Trust Direct Indexing L.P. Has $362,000 Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

First Trust Direct Indexing L.P. raised its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 5.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,016 shares of the company’s stock after buying an additional 272 shares during the quarter. First Trust Direct Indexing L.P.’s holdings in Prestige Consumer Healthcare were worth $362,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in PBH. Norden Group LLC increased its stake in Prestige Consumer Healthcare by 40.6% in the 1st quarter. Norden Group LLC now owns 9,876 shares of the company’s stock valued at $717,000 after buying an additional 2,852 shares during the period. Diversify Advisory Services LLC acquired a new position in Prestige Consumer Healthcare in the 1st quarter valued at approximately $419,000. Mirae Asset Global Investments Co. Ltd. increased its stake in Prestige Consumer Healthcare by 6.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,579 shares of the company’s stock valued at $1,929,000 after buying an additional 1,543 shares during the period. BNP Paribas Financial Markets increased its stake in Prestige Consumer Healthcare by 143.4% in the 1st quarter. BNP Paribas Financial Markets now owns 51,246 shares of the company’s stock valued at $3,718,000 after buying an additional 30,191 shares during the period. Finally, Capstone Investment Advisors LLC increased its stake in Prestige Consumer Healthcare by 36.7% in the 1st quarter. Capstone Investment Advisors LLC now owns 6,949 shares of the company’s stock valued at $504,000 after buying an additional 1,866 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Stock Performance

PBH stock opened at $74.05 on Monday. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. The company has a market capitalization of $3.67 billion, a price-to-earnings ratio of 18.11, a P/E/G ratio of 2.08 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 12 month low of $56.61 and a 12 month high of $75.80. The firm has a 50 day moving average of $72.17 and a two-hundred day moving average of $69.58.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings data on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.86 by $0.04. The business had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. Prestige Consumer Healthcare’s quarterly revenue was down 4.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.06 EPS. As a group, equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Jefferies Financial Group reiterated a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $94.20.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.